Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
US8895027B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 2, 2012 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Mar 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides vectors that contain and express in vivo or in vitro FeLV antigens that elicit an immune response in animal or human against FeLV, compositions comprising said vectors and/or FeLV polypeptides, methods of vaccination against FeLV, and kits for use with such methods and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.